(RTTNews) - Enliven Therapeutics, Inc (ELVN) revealed Loss for its second quarter of -$25.34 million
The company's bottom line totaled -$25.34 million, or -$0.49 per share. This compares with -$19.95 million, or -$0.41 per share, last year.
Enliven Therapeutics, Inc earnings at a glance (GAAP) :
-Earnings: -$25.34 Mln. vs. -$19.95 Mln. last year. -EPS: -$0.49 vs. -$0.41 last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Enliven Therapeutics, Inc Q2 Loss Climbs
Published 2 months ago
Aug 13, 2025 at 8:58 PM
Negative
Auto